Acinetobacter pneumonia: a review.
Acinetobacter species are becoming a major cause of nosocomial infections, including hospital-acquired and ventilator-associated pneumonia. Acinetobacter species have become increasingly resistant to antibiotics over the past several years and currently present a significant challenge in treating these infections. Physicians now rely on older agents, such as polymyxins (colistin), for treatment. This paper reviews the epidemiology, treatment, and prevention of this emerging pathogen.
Hartzell
Joshua D
JD
Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. Joshua.Hartzell@na.amedd.army.mil
Kim
Andrew S
AS
Kortepeter
Mark G
MG
Moran
Kimberly A
KA
D000150:Acinetobacter / Q000187:drug effects; D000151:Acinetobacter Infections / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D006801:Humans; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy
D000900:Anti-Bacterial Agents